CHICAGO, Nov. 7, 2025 /PRNewswire/ — Recently, DAMON has successfully brought the SpeedX automated sorting system online in the United States. As Damon’s first parcel-express-industry integration project in North America, this “lightning” rollout has delivered a shining business card to the Americas that reads: “Chinese Integration × Chinese Speed.”

As a world-leading supplier of comprehensive logistics-system integration, DAMON has spent years immersed in e-commerce and parcel express operations, which has amassed deep engineering expertise and project-delivery experience. From the United States to Mexico, Brazil to Argentina, DAMON has delivered more than 20 turnkey projects for e-commerce, parcel express, 3PL, and food industries, creating replicable successful experience and earning repeat and business from extensive leading clients.

To better empower clients across the Americas, DAMON’s U.S. subsidiary has rapidly expanded its local workforce, strengthening capabilities in sales, technology, project management and after-sales service to deliver true “local-for-local” support. Meanwhile, DAMON has partnered with American firms to establish a local assembly plant to accelerate on-site fabrication and commissioning of core products, shorten delivery cycles and bring Chinese smart manufacturing to every corner of the continent.

Source: www.damon-group.com/company-news-171

Related Stock: Shanghai  688360

E-mail: marketing@damon-group.com

DUBAI, United Arab Emirates, Nov. 7, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is pleased to introduce the Alpha Referral program, enabling users to earn up to 30% commission on trading fees generated by their referred friends on Bybit Alpha.

The new commission structure applies when referred users meet specific qualification criteria. Referrers can earn commission on their qualified referees’ trading activities across Bybit Alpha, Spot, and Derivatives.

Trading Buddies: Building Lasting Friendship for Long-Term Rewards

To generate commission for referrers, new users must meet the following qualification requirements:

• Registering using a referral link or code
• Depositing a minimum of 100 USDT within seven days of registration
• Completing at least 500 USDT in trading volume across Spot, Derivatives, or Bybit Alpha within 30 days

Once these criteria are met, commission earnings begin automatically for the referrer.

The commission program runs alongside Bybit’s existing Alpha Referral Campaign, which offers airdrop bonuses to both referrers and their qualified referees for trading activity on the Alpha platform.

Bybit Alpha: Alpha Rewards, Zero Friction

Since its upgrade, the brand new Bybit Alpha has been connecting traders to onchain opportunities through a seamless experience and with its hypersensitive alpha radar.

Bybit Alpha makes trading high-potential tokens of emerging projects as easy as Spot trading by removing the need to prepare new wallets and gas tokens. The platform offers:

• One-tap onchain access: Users can begin trading immediately without setting up external wallets or acquiring gas tokens
• Seamless exit: Traders can transfer assets back to their Bybit account without friction
• High-yield trending tokens: Access to emerging projects with significant growth potential

The platform serves as a powerful tool for alpha hunting, featuring minimum listing time and its signature Hot Token Screener, enabling users to track and capture the latest opportunities in the onchain space with minimal effort.

Terms and conditions apply. For details on qualification rules and eligibility, users may visit: Bybit Alpha referral commission: Invite friends and earn up to 30% commission

Participants can monitor their referral performance, track earnings, and manage their network through their personal referral dashboard: Bybit – My Referrals

#Bybit / #CryptoArk / #IMakeIt

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 70 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

SHANGHAI, Nov. 7, 2025 /PRNewswire/ — During the 8th China International Import Expo (CIIE) at the National Exhibition and Convention Center, Pigeon unveiled its latest advances in feeding and baby care science under the theme “The Nest”.

23 Years in China: Pigeon Expands from Local Innovation to Global Leadership

Within the CIIE Consumer Goods exhibition area (Hall 6.1), Pigeon’s baby feeding bottles have become a signature highlight.

As the trusted global leader in high-quality, precision-engineered baby and maternity care products, Pigeon celebrates 23 years in China this year. Zhou Jianfeng, President of Pigeon China, said, “Our journey in China began by bringing products directly from Japan. Over time, Pigeon has deepened its commitment—building three manufacturing facilities and an R&D center in China, introducing advanced technologies and quality systems to deliver trusted solutions for local families. Today, these locally developed innovations, production capabilities, and insights are helping to shape our global business.”

This year, Pigeon’s Skincare Research Center in China debuted an iPSc derived infant epidermal skin model for infants, engineered with iPS cell technology derived from Nobel Prize-winning research. The model addresses a long-standing challenge in baby skincare—scientifically validating product efficacy for delicate infant skin. It is now being applied in-house to develop and test Pigeon’s proprietary formulations, including the brand’s flagship 2025 introduction—the Vernix Baby Skincare Series.

70 Years of Pigeon Bottle Evolution: Honoring the Bond Between Parent and Child

At Pigeon’s booth, visitors explored the brand’s 70-year heritage of feeding innovation. In 1949, Pigeon transformed infant feeding with its first nursing bottle, featuring a screw-on wide-neck design that set a new benchmark for ease and comfort, differentiating it from the straight-insert method at the time. Today, Pigeon’s third generation Soft touch Wide-Neck Nursing Bottle, created to closely replicate the nursing experience, supports millions of newborn families worldwide. The brand also understands the modern parent’s focus on design and lifestyle, combining technical excellence with fresh, expressive aesthetics.

In China, Pigeon also focuses on supporting infants with special needs. To date, more than 36,000 children born with cleft lip and palate have benefited from Pigeon’s support programs, and over 9,000 premature babies have received essential nutrition through Pigeon-supported breast milk banks in NICU care. At CIIE 2025, Pigeon also signed a renewed strategic cooperation agreement with the National Center for Women and Children’s Health to further strengthen science-based infant feeding and maternal wellness initiatives.

SHANGHAI, Nov. 7, 2025 /PRNewswire/ — UNISOC recently launched the “ChipFire” classroom, a global science education program designed to inspire young people’s interest in technology. Through fun, hands-on learning, participants explore the world of chips and 5G. So far, over 10,000 teachers and students have joined the program to discover the power of innovation.

As a global innovative technology company, UNISOC is committed to sustainable and responsible innovation. Guided by ESG principles, the company promotes low-carbon development, digital inclusion, and people-centered technology innovation for a greener and fairer future.

Technology: Making the Earth Greener

Intelligent systems bring efficiency and convenience to modern life, yet energy consumption and environmental pressure are quietly rising—sustainable living has become a challenge each of us must face. UNISOC firmly believes that technology is more than speed and performance—it is also about gentleness and respect for the environment.

Through ongoing innovation in chip technology, UNISOC integrates green tech into daily life. Over the past year, our chips have supported billions of shared bikes, reducing more than 900,000 tons of carbon emissions; our 5G chip achieved a 40% reduction in core power consumption, eliminating approximately 816,000 tons of CO₂ per year—well below the industry average; in IoT applications, our high-efficiency chips helped partners optimize power consumption by an average of 20%, cutting about 310,000 tons of carbon emissions annually across global industries.

Looking ahead, we will continue to let technology illuminate a cleaner, more sustainable future.

Innovation: Bringing Connections Closer

In an age of ever-changing tech, we enjoy unprecedented intelligent experiences. Yet globally, three billion people still cannot access the digital world. While fast-moving technology certainly makes life more convenient, it can also widen the gap between people. UNISOC believes innovation is not about how far the technology can go—it is about how many people it can bring along. We hope that through our technology, connections will draw closer, and technology will become more equal.

Devices powered by UNISOC are enabling more people to enjoy digital life with warmth. UNISOC products now reach over 140 countries and regions; globally, one out of every 8 smartphones is powered by UNISOC , one out of every 4 cellular IoT devices is powered by UNISOC. From the first video call in remote areas to elder-care moments under real-time protection, UNISOC and its partners have launched senior-friendly smartphones and health-monitoring watches, helping tens of millions of elderly integrate into digital life; from Smart Home to child safety guardians. Working deeply in children smart wearables market, UNISOC has already protected over 100 million children worldwide. In UNISOC’s public education program — the “ChipFire” classroom — more than 10,000 young people each year experience science and innovation up close through hands-on experiments. UNISOC enabled smart POS terminals also bring convenient smart-payment experiences to small businesses on every street corner, supporting every dream.

We build bridges through technology, so that the innovation reach every person. In the future, UNISOC hopes to make innovation boundless, and connection borderless. With every leap of technology, we move closer and live warmer lives.

Responsibility: Making Innovation More Trustworthy

In today’s accelerating digital wave, technological innovation is not just a race for speed—it is a test of trust. From responsible operations to low-carbon practices, every link directly affects how people trust technology. UNISOC deeply believes that sound governance is the foundation of innovation; only within a clear, transparent and efficient system can every technological breakthrough truly become trustworthy.

We integrate ESG principles into our corporate strategy and daily management—leveraging digitalization to enhance efficiency, and institutional frameworks to ensure transparency. We strictly implement the ISO 14064 greenhouse-gas verification standard, and we rely on a carbon-emissions management platform to systemically manage greenhouse-gas data. During the reporting period, UNISOC achieved total greenhouse-gas emissions of 14,876.8 tons CO₂e, with an emission intensity of only 0.94 tons CO₂e per million-RMB revenue—far below industry average. In addition, we advance green office practices to promote low-carbon and high-efficiency parallel operations. Smart offices, green meetings and paperless workflows all make work more efficient and everyday sustainability more real.

As a global technology enterprise, UNISOC fully understands that social responsibility is not only a task—it is a long-term commitment. Going forward, UNISOC will continue to work hand-in-hand with global customers, partners and society, jointly advancing low-carbon and sustainable development, so that every technological innovation becomes even more worthy of trust. making innovation accessible to everyone, everywhere.

GUANGZHOU, China, Nov. 7, 2025 /PRNewswire/ — The apparel industry, one of China’s three conventional pillar export sectors alongside home appliances and furniture, is entering a new phase of transformation. Innovation is becoming the key driver of sustainable growth. At Phase 3 of the 138th Canton Fair, Chinese apparel manufacturers showcased how advances in technology, design, and management are reshaping the sector. The shift from scale-driven expansion to high-quality, intelligent, and environmentally conscious production reflects China’s broader push to cultivate new quality productive forces.

In response to growing global demand for sustainable fashion, exhibitors showcased a new generation of eco-friendly apparel that redefines material innovation. One Ningbo-based manufacturer presented garments made from GOTS-certified organic cotton and recycled polyester fibers, achieving a 40% reduction in water consumption per unit and earning GRS global recycling certification. These achievements are supported by the company’s smart manufacturing system, which integrates 3D digital design and automated cutting technologies. The result is a 50% increase in production efficiency and a defect rate below 0.5%, marking a significant leap in precision and sustainability.

Innovation in functional design also took center stage. A manufacturer from Jilin introduced heated apparel incorporating built-in electric elements to provide active warmth for cold environments. This product has already gained strong traction in the U.S. market. The company’s cooling garments, designed with advanced ventilation components, offer comfort in hot climates and are gradually expanding into European and American markets. The company’s fashion-forward workwear line, which merges protective utility with contemporary design, has likewise emerged as a trend across Europe. Together, these products highlight how Chinese manufacturers are integrating technology and fashion as new quality productive forces to drive growth.

Beyond material and product innovation, digital transformation is redefining the apparel supply chain. A Hangzhou-based company has established international design teams in New York, London, and Hangzhou to monitor global fashion trends in real time, while coordinating over 100 certified partner factories across Asia. Its fully certified production network emphasizes recycled materials and low-carbon solutions. Supported by flexible supply chain systems, the company enables rapid market response and global collaboration.

As global fashion evolves, Chinese apparel manufacturers are positioning themselves at the forefront of change. By embracing sustainable materials, intelligent design, and digitally integrated supply chains, they help shape a smarter, greener, and more globally connected future for fashion.

More about Canton Fair, please click https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

• Clinically and statistically significant superiority of AP301 maintenance dose versus ineffective low dose in reducing serum phosphate levels was established and AP301’s efficacy is sustained throughout the 52 weeks of treatment.
• The non-inferiority of AP301 to sevelamer carbonate in reducing serum phosphate levels was demonstrated.
• Overall, AP301 was safe and well-tolerated. The most common AEs were discolored feces and diarrhea. Diarrhea generally occurred early and resolved without treatment changes.
• No evidence of iron accumulation was observed with cumulative AP301 exposure.

SHANGHAI, Nov. 7, 2025 /PRNewswire/ — Alebund Pharmaceuticals (“Alebund” or the “Company”), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, presented the pivotal phase 3 study results of AP301 in patients on hemodialysis and peritoneal dialysis with hyperphosphatemia (RESPOND-1 study, NCT07030595) at the American Society of Nephrology (ASN) 2025 Congress in Houston, Texas.

AP301 is a novel fiber-iron-based phosphate binder that offers high phosphate-binding capability, does not require chewing before swallowing, does not expand in volume when exposed to gastric fluid, and is not systemically absorbed. These features contribute to a reduced pill burden, improved tolerability, and enhanced patient adherence.

The RESPOND-1 study was a randomized, open-label, active-controlled, multi-center study designed to evaluate the efficacy and safety of AP301 in controlling serum phosphate levels in dialysis patients with hyperphosphatemia. The 52-week study included an active control phase, an AP301 low-dose control phase, and an extended treatment phase. Sevelamer carbonate served as the active comparator throughout the entire study period. The study was conducted at 50 investigational sites in China, and was led by Professor Li ZUO, Director of the Department of Nephrology at Peking University People’s Hospital.

In this study:

• Of 692 participants screened, 474 participants were randomized (3:1) to the AP301 or sevelamer carbonate arm; 187 eligible participants in AP301 arm were further re-randomized (1:1) at Week 24 to the AP301 maintenance dose (N=94) or low dose (N=93) arm. Overall, 396 (84%) participants completed the study.
• The primary efficacy endpoints included: 1) the change in serum phosphate levels during the low dose control phase from Week 24 to Week 27 between the AP301 maintenance dose and low dose arm in responders defined as serum phosphate level <1.78 mmol/L (5.5 mg/dL) by Week 20; 2) the change in serum phosphate levels from baseline to Week 12 between AP301 and sevelamer carbonate during active control phase.
• At week 12, AP301 demonstrated non-inferiority to sevelamer carbonate, with a least squares mean (LSM) difference of -0.02 mmol/L（95% confidence interval (CI): -0.10, 0.06）[-0.06 mg/dL (95% CI: -0.31, 0.20)]; the upper CI bound of 0.06 mmol/L (0.20 mg/dL) was below the pre-defined non-inferiority margin (NIM) of 0.19 mmol/L (0.59 mg/dL). (see Figure 1)
• At week 27, AP301 maintenance dose showed a clinically and statistically significant superiority on serum phosphate control over an ineffective AP301 low dose in the low dose control phase {LSM difference -0.58 mmol/L (95% CI: -0.69, -0.47; P <0.001) [-1.8 mg/dL (95% CI: –2.1, –1.5; P <0.001)]}. (see Figure 2)
• AP301 achieved robust and sustained serum phosphate reduction over 52 weeks, suggesting its long-term therapeutic benefit (See Figure 3). It also showed a numerically higher serum phosphate response rate in the AP301 arm (66.7%) compared to the sevelamer carbonate arm (58.6%) at Week 52, and with a lower mean daily dose exposure (6.52 g/day in AP301 versus 7.56 g/day in sevelamer carbonate).
• Most participants experienced at least one AE (96.3% in AP301 and 90.8% in sevelamer carbonate). Diarrhea was the most common AE leading to study discontinuation in the AP301 arm (2/355, 0.6%), typically occurring within the first 2–4 weeks and predominantly mild in severity.
• Iron parameters changed from baseline mainly during the first 24 weeks, then stabilized or decelerated thereafter. No evidence of iron accumulation was observed with cumulative AP301 exposure.

Presentation Details at The American Society of Nephrology (ASN) 2025 Congress

Date: November 6, 2025

Title: 52-Week Phase 3 Study to Evaluate the Efficacy and Safety of a Novel Iron-Based Phosphate Binder AP301 in Patients on Dialysis with Hyperphosphatemia

“Iron-based phosphate binders have been used with increasing frequency in recent years for certain advantages. As a new generation of iron-based phosphate binder, AP301 is well differentiated from other iron-based phosphate binders with no systemic absorption and no need to chew or crush before swallowing. This pivotal trial demonstrates the clinical value of AP301 and its potential to advance the treatment option for patients with hyperphosphatemia.” Dr. Jin Tian, Co-founder and Chief Medical Officer of Alebund, commented, “Alebund is actively engaging in discussions with the China National Medical Products Administration regarding the new drug application plan for AP301.”

About Hyperphosphatemia

Hyperphosphatemia is one of the most common complications in CKD patients. The long-term elevated serum phosphate levels could cause multiple complications such as secondary hyperparathyroidism, renal osteodystrophy, and vascular calcification. It is an independent risk factor of cardiovascular events and all-cause mortalities. Good control of serum phosphate levels could effectively improve the patients’ outcome. For CKD patients undergoing dialysis treatment, regular dialysis is not sufficient to remove the excess serum phosphate in the body. Considering the limitations of low-phosphate diet which might cause dystrophia, oral use of phosphate binders is the prevailing treatment for hyperphosphatemia. However, existing phosphate binders lead to low patient compliance, with less than 50% of patients achieving good phosphate control, due to gastrointestinal side effects and high pill burden, etc.

According to the Global and Chinese Hyperphosphatemia Drug Industry Blue Book by China Insights Consultancy in 2023, the out-of-target rate of serum phosphate level in dialysis patients in Chinese mainland was significantly higher than that in other countries and regions. There remains substantial room for improvement in terms of the proportion of patients using phosphate binders and duration of their usage. The market size of serum phosphorus-lowering products in China is expected to reach RMB10 billion by 2035.

About Alebund Pharmaceuticals

Alebund was founded in Shanghai in 2018. The Company focuses on the discovery, development, manufacturing, and commercialization of novel therapies primarily for kidney diseases and their complications, as well as other chronic conditions, to bring better therapeutic options to patients in China and globally. Alebund has built a diversified and balanced pipeline of seven drug candidates and one commercialized product (Mircera^®) targeting a broad range of renal indications, including chronic kidney disease (CKD) and CKD complications, such as hyperphosphatemia, renal anemia, IgA nephropathy, diabetic kidney disease, focal segmental glomerulosclerosis (FSGS), and autosomal dominant polycystic kidney disease (ADPKD). Alebund has completed the construction of its manufacturing site in Yangzhou that will supply both drug substance and drug products of our product candidates, including AP301, upon commercial launch. Alebund has also established a dedicated in-house commercialization team in China responsible for promoting our renal products.

• Earns Platinum Medal from EcoVadis for sustainability performance
• Strengthens 2050 Net-Zero Commitment and Expands Global ESG Risk Management Framework

SEOUL, South Korea, Nov. 7, 2025 /PRNewswire/ — HS Hyosung Advanced Materials has earned the Platinum Medal, the highest grade, in the 2025 sustainability assessment conducted by Ecovadis. EcoVadis is a leading independent provider of corporate sustainability ratings and supply chain ESG assessments.

In this year’s comprehensive evaluation, HS Hyosung Advanced Materials was recognized for its superior performance across all measured categories: Environment, Labor & Human Rights, Ethics & Fair Business Practices, and Sustainable Procurement. This outstanding outcome placed the company in the top 1% of the more than 130,000 companies assessed worldwide. Prior to this, HS Hyosung Advanced Materials had secured the Gold Medal for three consecutive years starting in 2021.

This recognition reflects HS Hyosung Advanced Materials’ demonstrated progress in reducing carbon emissions and strengthening sustainability governance, including its Science Based Targets initiative (SBTi)-verified emissions reduction goals and 2050 Net-Zero roadmap. The company also conducted comprehensive human rights impact assessments across its global operations, implemented a supplier ESG risk monitoring and on-site audit program, and enhanced compliance and ethics systems across its international subsidiaries.

HS Hyosung Advanced Materials’ leadership in sustainability has also been validated by other independent benchmarks, including an A rating from the Korea Institute of Corporate Governance and Sustainability (KCGS) for four consecutive years, and two consecutive years of inclusion in the Dow Jones Sustainability Korea Index (DJSI Korea). Together, these sustained achievements underpin the company’s Platinum recognition from EcoVadis.

Headquartered in France, EcoVadis is a globally recognized provider of business sustainability ratings that evaluates companies worldwide across four key themes: Environment, Labor & Human Rights, Ethics & Fair Business Practices, and Sustainable Procurement. Based on performance, the top 1% of companies received Platinum recognition, followed by Gold (top 3%), Silver (top 15%), and Bronze (top 35%).

Jin Dal Lim, CEO of HS Hyosung Advanced Materials, commented, “Earning the EcoVadis Platinum Medal for the second consecutive year is a testament to our organization’s is a testament to how deeply sustainability is embedded across our operations. This achievement reflects our ongoing commitment to innovation, transparency, and accountability across our global supply chain. We remain focused on accelerating our climate action strategy and driving social impact initiatives that strengthen stakeholder trust and long-term business value.”

In parallel, HS Hyosung Advanced Materials continues to embed ESG priorities across its operations through four core focus areas of its global sustainability framework: ‘Zero Harm’ for workplace safety and health; ‘Zero Emissions’ for decarbonization and low-carbon materials innovation; ‘Zero Waste’ for resource efficiency and circularity; and ‘Zero Impact’ for responsible value-chain stewardship. This framework is overseen by the company’s Sustainability Management Committee, chaired by the CEO, with specialized subcommittees driving implementation across the enterprise. Through this structure, the company aims to create measurable value for customers, investors, and society while contributing to a more sustainable future.